{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:37:36Z","timestamp":1793216256386,"version":"4.5.0"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T00:00:00Z","timestamp":1499644800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Akrimax Pharmaceuticals, LLC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s40618-017-0706-y","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T06:50:07Z","timestamp":1499669407000},"page":"1289-1301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report"],"prefix":"10.1007","volume":"40","author":[{"given":"M.","family":"Centanni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Benvenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Sachmechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,10]]},"reference":[{"key":"706_CR1","first-page":"114","volume":"62","author":"DJ Lips","year":"2004","unstructured":"Lips DJ, van Reisen MT, Voigt V, Venekamp W (2004) Diagnosis and treatment of levothyroxine pseudomalabsorption. Neth J Med 62:114\u2013118","journal-title":"Neth J Med"},{"key":"706_CR2","doi-asserted-by":"crossref","first-page":"E419","DOI":"10.1210\/jc.2011-1851","volume":"97","author":"C Virili","year":"2012","unstructured":"Virili C, Bassotti G, Santaguida MG et al (2012) Atypical celiac disease as cause of increased need for thyroxine: a systematic study. J Clin Endocrinol Metab 97:E419\u2013E422","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR3","doi-asserted-by":"crossref","first-page":"E1454","DOI":"10.1210\/jc.2014-1217","volume":"99","author":"M Cellini","year":"2014","unstructured":"Cellini M, Santaguida MG, Gatto I et al (2014) Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine. J Clin Endocrinol Metab 99:E1454\u2013E1458","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/thy.1995.5.249","volume":"5","author":"S Benvenga","year":"1995","unstructured":"Benvenga S, Bartolone L, Squadrito S, Lo Giudice F, Trimarchi F (1995) Delayed intestinal absorption of levothyroxine. Thyroid 5:249\u2013253","journal-title":"Thyroid"},{"key":"706_CR5","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa043903","volume":"354","author":"M Centanni","year":"2006","unstructured":"Centanni M, Gargano L, Canettieri G et al (2006) Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med 354:1787\u20131795","journal-title":"N Engl J Med"},{"key":"706_CR6","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1136\/pmj.2006.049809","volume":"82","author":"SGS Krishnan","year":"2006","unstructured":"Krishnan SGS, Pathalapati R, Kaplan L, Cobbs RK (2006) Falsely raised TSH levels due to human anti-mouse antibody interfering with thyrotropin assay. Postgrad Med J 82:e27","journal-title":"Postgrad Med J"},{"key":"706_CR7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4158\/EP.13.4.345","volume":"13","author":"I Sachmechi","year":"2007","unstructured":"Sachmechi I, Reich DM, Aninyei M, Wibowo F, Gupta G, Kim PJ (2007) Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. Endocr Pract 13:345\u2013349","journal-title":"Endocr Pract"},{"key":"706_CR8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1503\/cmaj.110994","volume":"184","author":"A Ramadhan","year":"2012","unstructured":"Ramadhan A, Tamilia M (2012) Treatment-refractory hypothyroidism. CMAJ 184:205\u2013209","journal-title":"CMAJ"},{"key":"706_CR9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MED.0000000000000003","volume":"20","author":"S Benvenga","year":"2013","unstructured":"Benvenga S (2013) When thyroid hormone replacement is ineffective? Curr Opin Endocrinol Diabetes Obes 20:467\u2013477","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"706_CR10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12020-012-9814-9","volume":"43","author":"M Centanni","year":"2013","unstructured":"Centanni M (2013) Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches. Endocrine 43:8\u20139","journal-title":"Endocrine"},{"key":"706_CR11","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1210\/jcem-71-3-764","volume":"71","author":"DS Ross","year":"1990","unstructured":"Ross DS, Daniels GH, Gouveia D (1990) The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic. J Clin Endocrinol Metab 71:764\u2013769","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR12","first-page":"107","volume":"43","author":"JV Parle","year":"1993","unstructured":"Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC (1993) Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract 43:107\u2013109","journal-title":"Br J Gen Pract"},{"key":"706_CR13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","volume":"160","author":"GJ Canaris","year":"2000","unstructured":"Canaris GJ, Manowitz NR, Mayor G, Ridgway EC (2000) The colorado thyroid disease prevalence study. Arch Intern Med 160:526\u2013534","journal-title":"Arch Intern Med"},{"key":"706_CR14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","volume":"87","author":"JG Hollowell","year":"2002","unstructured":"Hollowell JG, Staehling NW, Flanders WD et al (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988\u20131994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489\u2013499","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR15","first-page":"485","volume":"36","author":"F Vaisman","year":"2013","unstructured":"Vaisman F, Coeli CM, Ward LS et al (2013) How good is the levothyroxine replacement in primary hypothyroidism patients in Brazil? Data of a multicentre study. J Endocrinol Invest 36:485\u2013488","journal-title":"J Endocrinol Invest"},{"key":"706_CR16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/thy.2008.0206","volume":"19","author":"B Hallengren","year":"2009","unstructured":"Hallengren B, Lantz M, Andreasson B, Grennert L (2009) Pregnant women on thyroxine substitution are often dysregulated in early pregnancy. Thyroid 19:391\u2013394","journal-title":"Thyroid"},{"key":"706_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fendo.2017.00092","volume":"8","author":"M Cellini","year":"2017","unstructured":"Cellini M, Santaguida MG, Virili C et al (2017) Hashimoto\u2019s thyroiditis and autoimmune gastritis. Front Endocrinol (Lausanne) 8:92 doi: 10.3389\/fendo.2017.00092","journal-title":"Front Endocrinol (Lausanne)"},{"key":"706_CR18","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1089\/thy.2014.0028","volume":"24","author":"J Jonklaas","year":"2014","unstructured":"Jonklaas J, Bianco AC, Bauer AJ et al (2014) Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on thyroid hormone replacement. Thyroid 24:1670\u20131751","journal-title":"Thyroid"},{"key":"706_CR19","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s40618-016-0511-z","volume":"39","author":"B Biondi","year":"2016","unstructured":"Biondi B, Bartalena L, Chiovato L et al (2016) Recommendations for treatment of hypothyroidism with levothyroxine and levotriiodothyronine: a 2016 position statement of the Italian Society of Endocrinology and the Italian Thyroid Association. J Endocrinol Invest 39:1465\u20131474","journal-title":"J Endocrinol Invest"},{"key":"706_CR20","volume-title":"Medicine use and shifting costs of healthcare: a review of the use of medicines in the United States in 2013","author":"M Aitken","year":"2014","unstructured":"Aitken M, Kleinrock M, Lyle J, Caskey L (2014) Medicine use and shifting costs of healthcare: a review of the use of medicines in the United States in 2013. IMS Institute for Healthcare Informatics. IMS Health, Danbury"},{"key":"706_CR21","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1089\/thy.2012.0205","volume":"22","author":"JR Garber","year":"2012","unstructured":"Garber JR, Cobin RH, Gharib H et al (2012) Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid 22:1200\u20131233","journal-title":"Thyroid"},{"key":"706_CR22","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1172\/JCI105234","volume":"44","author":"RD Utiger","year":"1965","unstructured":"Utiger RD (1965) Radioimmunoassay of human plasma thyrotropin. J Clin Invest 44:1277\u20131286","journal-title":"J Clin Invest"},{"key":"706_CR23","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJM198504253121703","volume":"312","author":"P Beck-Peccoz","year":"1985","unstructured":"Beck-Peccoz P, Amr S, Menezes-Ferreira MM, Faglia G, Weintraub BD (1985) Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone. N Engl J Med 312:1085\u20131090","journal-title":"N Engl J Med"},{"key":"706_CR24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0889-8529(05)70187-0","volume":"30","author":"JR Stockigt","year":"2001","unstructured":"Stockigt JR (2001) Free thyroid hormone measurement. A critical appraisal. Endocrinol Metab Clin N Am 30:265\u2013289","journal-title":"Endocrinol Metab Clin N Am"},{"key":"706_CR25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1210\/edrv.23.1.0455","volume":"23","author":"AC Bianco","year":"2002","unstructured":"Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR (2002) Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38\u201389","journal-title":"Endocr Rev"},{"key":"706_CR26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0002-9343(82)90565-4","volume":"72","author":"MM Kaplan","year":"1982","unstructured":"Kaplan MM, Larsen PR, Crantz FR, Dzau VJ, Rossing TH, Haddow JE (1982) Prevalence of abnormal thyroid function test results in patients with acute medical illnesses. Am J Med 72:9\u201316","journal-title":"Am J Med"},{"key":"706_CR27","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1210\/jc.2002-022013","volume":"88","author":"RP Peeters","year":"2003","unstructured":"Peeters RP, Wouters PJ, Kaptein E, van Toor H, Visser TJ, Van den Berghe G (2003) Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 88:3202\u20133211","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamainternmed.2013.11312","volume":"174","author":"PN Taylor","year":"2014","unstructured":"Taylor PN, Iqbal A, Minassian C et al (2014) Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Intern Med 174:32\u201339","journal-title":"JAMA Intern Med"},{"key":"706_CR29","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1210\/jc.2005-1013","volume":"12","author":"RP Peeters","year":"2005","unstructured":"Peeters RP, van der Geyten S, Wouters PJ et al (2005) Tissue thyroid hormone levels in critical illness. J Clin Endocrinol Metab 12:6498\u20136507","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR30","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1210\/jc.2005-0535","volume":"90","author":"RP Peeters","year":"2005","unstructured":"Peeters RP, Wouters PJ, van Toor H, Kaptein E, Visser TJ et al (2005) Serum 3,3\u2032,5\u2032-triiodothyronine (rT3) and 3,5,3\u2032-triiodothyronine\/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab 90:4559\u20134565","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2265.1993.tb02401.x","volume":"39","author":"R Docter","year":"1993","unstructured":"Docter R, Krenning EP, de Jong M, Hennemann G (1993) The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxf) 39:499\u2013518","journal-title":"Clin Endocrinol (Oxf)"},{"key":"706_CR32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/beem.2001.0163","volume":"15","author":"E Fliers","year":"2001","unstructured":"Fliers E, Alkemade A, Wiersinga WM (2001) The hypothalamic-pituitary-thyroid axis in critical illness. Best Pract Res Clin Endocrinol Metab 15:453\u2013464","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"706_CR33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/jcem.82.2.3745","volume":"82","author":"IJ Chopra","year":"1997","unstructured":"Chopra IJ (1997) Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab 82:329\u2013334","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1172\/JCI7771","volume":"106","author":"T Nagaya","year":"2000","unstructured":"Nagaya T, Fujieda M, Otsuka G, Yang JP, Okamoto T, Seo H (2000) A potential role of activated NF-Kappa B in the pathogenesis of euthyroid sick syndrome. J Clin Invest 106:393\u2013402","journal-title":"J Clin Invest"},{"key":"706_CR35","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1210\/jcem-71-6-1567","volume":"71","author":"T Poll van der","year":"1990","unstructured":"van der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP (1990) Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 71:1567\u20131572","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR36","first-page":"1342","volume":"79","author":"JM Stouthard","year":"1994","unstructured":"Stouthard JM, van der Poll T, Endert E et al (1994) Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab 79:1342\u20131346","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR37","first-page":"3140","volume":"80","author":"EP Corssmit","year":"1995","unstructured":"Corssmit EP, Heyligenberg R, Endert E, Sauerwein HP, Romijn JA (1995) Acute effects of interferon-alpha administration on thyroid hormone metabolism in healthy men. Clin Endocrinol Metab 80:3140\u20133144","journal-title":"Clin Endocrinol Metab"},{"key":"706_CR38","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1210\/jcem-41-6-1043","volume":"41","author":"IJ Chopra","year":"1975","unstructured":"Chopra IJ, Chopra U, Smith SR, Reza M, Solomon DH (1975) Reciprocal changes in serum concentrations of 3,3\u2032,5-triiodothyronine (T3) in systemic illnesses. J Clin Endocrinol Metab 41:1043\u20131049","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR39","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0006-291X(88)80488-1","volume":"151","author":"JL Leonard","year":"1988","unstructured":"Leonard JL (1988) Dibutyryl cAMP induction of type II 5\u2032 deiodinase activity in rat brain astrocytes in culture. Biochem Biophys Res Commun 151:1164\u20131172","journal-title":"Biochem Biophys Res Commun"},{"key":"706_CR40","unstructured":"Holtorf K Deiodinases. https:\/\/www.nahypothyroidism.org\/deiodinases\/print\/ . Accessed 1 Oct 2016"},{"key":"706_CR41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2265.2009.03536.x","volume":"70","author":"JC Morris","year":"2009","unstructured":"Morris JC (2009) How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement? Clin Endocrinol 70:671\u2013673","journal-title":"Clin Endocrinol"},{"key":"706_CR42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s40268-015-0116-6","volume":"16","author":"M McMillan","year":"2016","unstructured":"McMillan M, Rotenberg KS, Vora K et al (2016) Comorbidities, concomitant medications, and diet as factors affecting levothyroxine therapy: results of the CONTROL Surveillance Project. Drugs R D 16:53\u201368","journal-title":"Drugs R D"},{"key":"706_CR43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4158\/EP0362.OR","volume":"16","author":"JV Hennessey","year":"2010","unstructured":"Hennessey JV, Malabanan AO, Haugen BR, Levy EG (2010) Adverse event reporting in patients treated with levothyroxine: results of the pharmacovigilance task force survey of the American Thyroid Association, American Association of Clinical Endocrinologists, and the Endocrine Society. Endocr Prac 16:357\u2013370","journal-title":"Endocr Prac"},{"key":"706_CR44","unstructured":"Sachmechi I (1997) Vitamin D reduces thyroxine efficacy in patients on l-thyroxine therapy AACE 6th Annual Meeting 134.4"},{"key":"706_CR45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1530\/acta.0.1100483","volume":"110","author":"K Hasselstr\u00f6m","year":"1985","unstructured":"Hasselstr\u00f6m K, Siersbaek-Nielsen K, Lumholtz IB, Faber J, Kirkegaard C, Friis T (1985) The bioavailability of thyroxine and 3,5,3\u2032-triiodothyronine in normal subjects and in hyper- and hypothyroid patients. Acta Endocrinol (Copenh) 110:483\u2013486","journal-title":"Acta Endocrinol (Copenh)"},{"key":"706_CR46","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1001\/archinte.159.15.1726","volume":"159","author":"M Centanni","year":"1999","unstructured":"Centanni M, Marignani M, Gargano L et al (1999) Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association. Arch Intern Med 159:1726\u20131730","journal-title":"Arch Intern Med"},{"key":"706_CR47","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2146\/ajhp060033","volume":"63","author":"AD Miller","year":"2006","unstructured":"Miller AD, Smith KM (2006) Medication and nutrient administration considerations after bariatric surgery. Am J Health Syst Pharm 63:1852\u20131857","journal-title":"Am J Health Syst Pharm"},{"key":"706_CR48","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1210\/jc.2009-0860","volume":"94","author":"TG Bach-Huynh","year":"2009","unstructured":"Bach-Huynh TG, Nayak B, Loh J, Soldin S, Jonklaas J (2009) Timing of levothyroxine administration affects serum thyrotropin concentration. J Clin Endocrinol Metab 94:3905\u20133912","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR49","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.beem.2009.06.006","volume":"23","author":"L Liwanpo","year":"2009","unstructured":"Liwanpo L, Hershman JM (2009) Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab 23:781\u2013792","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"706_CR50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejpb.2008.10.008","volume":"72","author":"D Pabla","year":"2009","unstructured":"Pabla D, Akhlaghi F, Zia H (2009) A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry. Eur J Pharm Biopharm 72:105\u2013110","journal-title":"Eur J Pharm Biopharm"},{"key":"706_CR51","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/S0004-27302010000500002","volume":"54","author":"LS Ward","year":"2010","unstructured":"Ward LS (2010) The difficult patient: drug interaction and the influence of concomitant diseases on the treatment of hypothyroidism. Arq Brasil Endocrinol Metab 54:435\u2013442","journal-title":"Arq Brasil Endocrinol Metab"},{"key":"706_CR52","first-page":"318","volume":"63","author":"M Ruchala","year":"2012","unstructured":"Ruchala M, Szczepanek-Parulska E, Zybek A (2012) The influence of lactose intolerance and other gastro-intestinal tract disorders on l-thyroxine absorption. Endokrynol Pol 63:318\u2013323","journal-title":"Endokrynol Pol"},{"key":"706_CR53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/11598070-000000000-00000","volume":"72","author":"D Khandelwal","year":"2012","unstructured":"Khandelwal D, Tandon N (2012) Overt and subclinical hypothyroidism: who to treat and how. Drugs 72:17\u201333","journal-title":"Drugs"},{"key":"706_CR54","first-page":"244","volume":"86","author":"DY Gaitonde","year":"2012","unstructured":"Gaitonde DY, Rowley KD, Sweeney LB (2012) Hypothyroidism: an update. Am Fam Physician 86:244\u2013251","journal-title":"Am Fam Physician"},{"key":"706_CR55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.12659\/AJCR.883788","volume":"14","author":"JB Groener","year":"2013","unstructured":"Groener JB, Lehnhoff D, Piel D, Nawroth PP, Schanz J, Rudofsky G (2013) Subcutaneous application of levothyroxine as successful treatment option in a patient with malabsorption. Am J Case Rep 14:48\u201351","journal-title":"Am J Case Rep"},{"key":"706_CR56","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/cen.12559","volume":"82","author":"SA Irving","year":"2015","unstructured":"Irving SA, Vadiveloo T, Leese GP (2015) Drugs that interact with levothyroxine: an observational study from the Thyroid Epidemiology, Audit and Research Study (TEARS). Clin Endocrinol (Oxf) 82:136\u2013141","journal-title":"Clin Endocrinol (Oxf)"},{"key":"706_CR57","first-page":"451","volume":"18","author":"G Ianiro","year":"2014","unstructured":"Ianiro G, Mangiola F, Di Rienzo TA et al (2014) Levothyroxine absorption in health and disease, and new therapeutic perspectives. Eur Rev Med Pharmacol Sci 18:451\u2013456","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"706_CR58","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40261-015-0271-0","volume":"35","author":"G Trifir\u00f2","year":"2015","unstructured":"Trifir\u00f2 G, Parrino F, Sultana J et al (2015) Drug interactions with levothyroxine therapy in patients with hypothyroidism: observational study in general practice. Clin Drug Investig 35:187\u2013195","journal-title":"Clin Drug Investig"},{"key":"706_CR59","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s40618-016-0445-5","volume":"39","author":"C Castoro","year":"2016","unstructured":"Castoro C, Le Moli R, Arpi ML et al (2016) Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution. J Endocrinol Invest 39:779\u2013784","journal-title":"J Endocrinol Invest"},{"key":"706_CR60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa040079","volume":"351","author":"EK Alexander","year":"2004","unstructured":"Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR (2004) Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 351:241\u2013249","journal-title":"N Engl J Med"},{"key":"706_CR61","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/FTD.0b013e3181f12fe5","volume":"32","author":"OP Soldin","year":"2010","unstructured":"Soldin OP, Soldin SJ, Vinks AA, Younis I, Landy HJ (2010) Longitudinal comparison of thyroxine pharmacokinetics between pregnant and nonpregnant women: a stable isotope study. Ther Drug Monit 32:767\u2013773","journal-title":"Ther Drug Monit"},{"key":"706_CR62","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1001\/jama.1991.03470150090036","volume":"266","author":"KB Ain","year":"1991","unstructured":"Ain KB, Refetoff S, Fein HG, Weintraub BD (1991) Pseudomalabsorption of levothyroxine. JAMA 266:2118\u20132120","journal-title":"JAMA"},{"key":"706_CR63","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11695-016-2247-4","volume":"27","author":"P Fallahi","year":"2017","unstructured":"Fallahi P, Ferrari SM, Camastra S et al (2017) TSH normalization in bariatric surgery patients after the switch from l-thyroxine in tablet to an oral liquid formulation. Obes Surg 27:78\u201382","journal-title":"Obes Surg"},{"key":"706_CR64","unstructured":"Committee for Proprietary Medicinal Products (1997) Federal Register 62: 25691\u201325709"},{"key":"706_CR65","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMcp1113994","volume":"367","author":"A Fasano","year":"2012","unstructured":"Fasano A, Catassi C (2012) Clinical practice, celiac disease. N Engl J Med 367:2419\u20132426","journal-title":"N Engl J Med"},{"key":"706_CR66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4292\/wjgpt.v5.i3.105","volume":"5","author":"R Badillo","year":"2014","unstructured":"Badillo R, Francis D (2014) Diagnosis and treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther 5:105\u2013112","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"706_CR67","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1007\/s10620-014-3181-8","volume":"59","author":"E Cohen","year":"2014","unstructured":"Cohen E, Bolus R, Khanna D et al (2014) GERD symptoms in the general population: prevalence and severity versus care-seeking patients. Dig Dis Sci 59:2488\u20132496","journal-title":"Dig Dis Sci"},{"key":"706_CR68","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.4158\/EP14051.CR","volume":"1","author":"PJ Kim","year":"2015","unstructured":"Kim PJ, Sachmechi I (2015) Levothyroxine malabsorption induced by diabetic gastroparesis exacerbated during pregnancies: effect of intramuscular levothyroxine injections and levothyroxine soft gel capsules. AACE Clin Case Rep 1:e73\u2013e78","journal-title":"AACE Clin Case Rep"},{"key":"706_CR69","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1089\/thy.2013.0661","volume":"24","author":"HM Robertson","year":"2014","unstructured":"Robertson HM, Narayanaswamy AK, Pereira O et al (2014) Factors contributing to high levothyroxine doses in primary hypothyroidism: an interventional audit of a large community database. Thyroid 24:1765\u20131771","journal-title":"Thyroid"},{"key":"706_CR70","doi-asserted-by":"crossref","first-page":"95","DOI":"10.15403\/jgld.2014.1121.fio","volume":"24","author":"G Fiorini","year":"2015","unstructured":"Fiorini G, Bland JM, Hughes E, Castelli V, Vaira D (2015) A systematic review on drugs absorption modifications after eradication in Helicobacter pylori positive patients undergoing replacement therapy. J Gastrointest Liver Dis 24:95\u2013100","journal-title":"J Gastrointest Liver Dis"},{"key":"706_CR71","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1210\/jc.2004-1306","volume":"90","author":"F Santini","year":"2005","unstructured":"Santini F, Pinchera A, Marsili A et al (2005) Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab 90:124\u2013127","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR72","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2265.2010.03940.x","volume":"74","author":"D Mistry","year":"2011","unstructured":"Mistry D, Atkin S, Atkinson H et al (2011) Predicting thyroxine requirements following total thyroidectomy. Clin Endocrinol (Oxf) 74:384\u2013387","journal-title":"Clin Endocrinol (Oxf)"},{"key":"706_CR73","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11695-009-0005-6","volume":"20","author":"D Gniuli","year":"2010","unstructured":"Gniuli D, Leccesi L, Guidone C et al (2010) Thyroid function and insulin sensitivity before and after bilio-pancreatic diversion. Obes Surg 20:61\u201368","journal-title":"Obes Surg"},{"key":"706_CR74","unstructured":"Bowthorpe J Is there a genetic reason many of us do lousy on T4? http:\/\/www.stopthethyroidmadness.com\/2009\/10\/28\/is-there-a-genetic-reason-many-of-us-do-lousy-on-t4 . Accessed 1 Oct 2016"},{"key":"706_CR75","doi-asserted-by":"crossref","first-page":"e22552","DOI":"10.1371\/journal.pone.0022552","volume":"6","author":"D Gullo","year":"2011","unstructured":"Gullo D, Latina A, Frasca F et al (2011) Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PLoS One 6:e22552","journal-title":"PLoS One"},{"key":"706_CR76","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1210\/jc.2009-0410","volume":"94","author":"BW Kim","year":"2009","unstructured":"Kim BW, Bianco AC (2009) For some, l-thyroxine replacement might not be enough: a genetic rationale. J Clin Endocrinol Metab 94:1521\u20131523","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR77","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1210\/jc.2005-0451","volume":"90","author":"BC Appelhof","year":"2005","unstructured":"Appelhof BC, Peeters RP, Wiersinga WM et al (2005) Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine\/3,5,3\u2032-triiodothyronine therapy. J Clin Endocrinol Metab 90:6296\u20136299","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR78","first-page":"376","volume":"16","author":"S Snyder","year":"2012","unstructured":"Snyder S, Listecki RE (2012) Bioidentical thyroid replacement therapy in practice: delivering a physiologic T4:T3 ratio for improved patient outcomes with the Listecki-Snyder protocol. Int J Pharm Compd 16:376\u2013380","journal-title":"Int J Pharm Compd"},{"key":"706_CR79","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF00442510","volume":"138","author":"F Luca De","year":"1982","unstructured":"De Luca F, Trimarchi F, Sferlazzas C et al (1982) Thyroid function in children with cystic fibrosis. Eur J Pediatr 138:327\u2013330","journal-title":"Eur J Pediatr"},{"key":"706_CR80","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0022-3476(84)80030-X","volume":"105","author":"F Delange","year":"1984","unstructured":"Delange F, Dalhem A, Bourdoux P et al (1984) Increased risk of primary hypothyroidism in preterm infants. J Pediatr 105:462\u2013469","journal-title":"J Pediatr"},{"key":"706_CR81","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1651-2227.1991.tb11768.x","volume":"80","author":"C Depasse","year":"1991","unstructured":"Depasse C, Chanoine JP, Casimir G, Van Vliet G (1991) Congenital hypothyroidism and cystic fibrosis. Acta Paediatr Scand 80:981\u2013983","journal-title":"Acta Paediatr Scand"},{"key":"706_CR82","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcf.2005.09.010","volume":"5","author":"AM Mc Laughlin","year":"2006","unstructured":"Mc Laughlin AM, Crotty TB, Egan JJ, Watson AJ, Gallagher CG (2006) Amyloidosis in cystic fibrosis: a case series. J Cyst Fibros 5:59\u201361","journal-title":"J Cyst Fibros"},{"key":"706_CR83","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2215\/CJN.00750209","volume":"4","author":"Y Yahiaoui","year":"2009","unstructured":"Yahiaoui Y, Jablonski M, Hubert D et al (2009) Renal involvement in cystic fibrosis: diseases spectrum and clinical relevance. Clin J Am Soc Nephrol 4:921\u2013928","journal-title":"Clin J Am Soc Nephrol"},{"key":"706_CR84","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/thy.1995.5.369","volume":"5","author":"MH Samuels","year":"1995","unstructured":"Samuels MH, Thompson N, Leichty D, Ridgway EC (1995) Amyloid goiter in cystic fibrosis. Thyroid 5:213\u2013215","journal-title":"Thyroid"},{"key":"706_CR85","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.med.0000137759.57791.f8","volume":"11","author":"S Benvenga","year":"2004","unstructured":"Benvenga S, Trimarchi F (2004) Increasing frequency and clinical significance of thyroid hormone autoantibodies. Curr Opin Endocrinol Diabetes Obes 11:209\u2013213","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"706_CR86","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0140-6736(91)90546-2","volume":"338","author":"V Fonseca","year":"1991","unstructured":"Fonseca V, Thomas M, Katrak A, Sweny P, Moorhead JF (1991) Can urinary thyroid hormone loss cause hypothyroidism? Lancet 338:475\u2013476","journal-title":"Lancet"},{"key":"706_CR87","first-page":"201","volume":"52","author":"NA Junglee","year":"2006","unstructured":"Junglee NA, Scanlon MF, Rees DA (2006) Increasing thyroxine requirements in primary hypothyroidism: don\u2019t forget the urinalysis! J Postgrad Med 52:201\u2013203","journal-title":"J Postgrad Med"},{"key":"706_CR88","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0022-1759(88)90296-7","volume":"115","author":"R Yamamoto","year":"1988","unstructured":"Yamamoto R, Kimura S, Ishizuki Y (1988) Enzyme immunoassay for antibodies to thyroxine in human serum using synthesized antibody as a calibrator. J Immunol Methods 115:263\u2013268","journal-title":"J Immunol Methods"},{"key":"706_CR89","first-page":"1487","volume":"58","author":"Y Suzuki","year":"1982","unstructured":"Suzuki Y, Takeshita E, Kano S, Hirata S, Sato S (1982) Impaired intestinal absorption of thyroid hormone in a case of Hashimoto\u2019s disease with anti-T3 and anti-T4 antibody. Nihon Naibunpi Gakkai Zasshi 58:1487\u20131497","journal-title":"Nihon Naibunpi Gakkai Zasshi"},{"key":"706_CR90","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1210\/jcem-28-6-749","volume":"28","author":"MT Hays","year":"1968","unstructured":"Hays MT (1968) Absorption of oral thyroxine in man. J Clin Endocrinol Metab 28:749\u2013756","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR91","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/thy.2000.10.93","volume":"10","author":"B Jauk","year":"2000","unstructured":"Jauk B, Mikosch P, Gallowitsch HJ et al (2000) Unusual malabsorption of levothyroxine. Thyroid 10:93\u201395","journal-title":"Thyroid"},{"key":"706_CR92","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1089\/thy.2006.16.1047","volume":"16","author":"A T\u00f6njes","year":"2006","unstructured":"T\u00f6njes A, Karger S, Koch CA et al (2006) Impaired enteral levothyroxine absorption in hypothyroidism refractory to oral therapy after thyroid ablation for papillary thyroid cancer: case report and kinetic studies. Thyroid 16:1047\u20131051","journal-title":"Thyroid"},{"key":"706_CR93","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4103\/2230-8210.95716","volume":"16","author":"N Damle","year":"2012","unstructured":"Damle N, Bal C, Soundararajan R, Kumar P, Durgapa P (2012) A curious case of refractory hypothyroidism due to selective malabsorption of oral thyroxine. Indian J Endocrinol Metab 16:466\u2013468","journal-title":"Indian J Endocrinol Metab"},{"key":"706_CR94","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s12020-014-0509-2","volume":"49","author":"C Virili","year":"2015","unstructured":"Virili C, Centanni M (2015) Does microbiota composition affect thyroid homeostasis? Endocrine 49:583\u2013587","journal-title":"Endocrine"},{"key":"706_CR95","first-page":"30075","volume":"S0303\u20137207","author":"C Virili","year":"2017","unstructured":"Virili C, Centanni M (2017) \u201cWith a little help from my friends\u201d-the role of microbiota in thyroid hormone metabolism and enterohepatic recycling. Mol Cell Endocrinol S0303\u20137207:30075\u201330078","journal-title":"Mol Cell Endocrinol"},{"key":"706_CR96","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7326\/0003-4819-134-7-200104030-00009","volume":"134","author":"DC Bauer","year":"2001","unstructured":"Bauer DC, Ettinger B, Nevitt MC, Stone KL (2001) Study of Osteoporotic Fractures Research Group. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 134:561\u2013568","journal-title":"Ann Intern Med"},{"key":"706_CR97","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1210\/jc.2009-1625","volume":"9","author":"RW Flynn","year":"2010","unstructured":"Flynn RW, Bonellie SR, Jung RT, MacDonald TM, Morris AD, Leese GP (2010) Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab 9:186\u2013193","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR98","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/jbmr.2416","volume":"30","author":"B Abrahamsen","year":"2015","unstructured":"Abrahamsen B, J\u00f8rgensen HL, Laulund AS et al (2015) The excess risk of major osteoporotic fractures in hypothyroidism is driven by cumulative hyperthyroid as opposed to hypothyroid time: an observational register-based time-resolved cohort analysis. J Bone Miner Res 30:898\u2013905","journal-title":"J Bone Miner Res"},{"key":"706_CR99","unstructured":"Shomon M The thyroid treatment\/osteoporosis controversy: does thyroid treatment contribute to loss of bone density? http:\/\/www.thyroid-info.com\/articles\/osteoporosis.htm . Accessed 1 Oct 2016"},{"key":"706_CR100","doi-asserted-by":"crossref","first-page":"638727","DOI":"10.1155\/2013\/638727","volume":"2013","author":"J Gorka","year":"2013","unstructured":"Gorka J, Taylor-Gjevre RM, Arnason T (2013) Metabolic and clinical consequences of hyperthyroidism on bone density. Int J Endocrinol 2013:638727","journal-title":"Int J Endocrinol"},{"key":"706_CR101","unstructured":"Lindner H Thyroid hormone: T3. http:\/\/www.hormonerestoration.com\/thyroid.html . Accessed 1 Oct 2016"},{"key":"706_CR102","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s40618-016-0488-7","volume":"39","author":"E Piantanida","year":"2016","unstructured":"Piantanida E, Gallo D, Veronesi G et al (2016) Masked hypertension in newly diagnosed hypothyroidism: a pilot study. J Endocrinol Invest 39:1131\u20131138","journal-title":"J Endocrinol Invest"},{"key":"706_CR103","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0661-7","author":"D Gallo","year":"2017","unstructured":"Gallo D, Piantanida E, Veronesi G et al (2017) Physical performance in newly diagnosed hypothyroidism: a pilot study. J Endocrinol Invest. doi: 10.1007\/s40618-017-0661-7","journal-title":"J Endocrinol Invest"},{"key":"706_CR104","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40261-016-0462-3","volume":"37","author":"FR Ernst","year":"2017","unstructured":"Ernst FR, Barr P, Elmor R, Sandulli W et al (2017) The economic impact of levothyroxine dose adjustments: the CONTROL HE Study. Clin Drug Investig 37:71\u201383","journal-title":"Clin Drug Investig"},{"key":"706_CR105","doi-asserted-by":"crossref","unstructured":"McMillan M, Sterman A, Engelken D, Sandulli W (2016) Levothyroxine dose changes and hypothyroid patient satisfaction\u2014results of the CONTROL TS Study. Abstract. 86th Annual Meeting of the American Thyroid Association, Denver","DOI":"10.26420\/annalsthyroidres.2017.1027"},{"key":"706_CR106","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1089\/105072502320288519","volume":"12","author":"L d\u2019Est\u00e8ve-Bonetti","year":"2002","unstructured":"d\u2019Est\u00e8ve-Bonetti L, Bennet AP, Malet D, Hoff M, Louvet JP, Caron P (2002) Gluten-induced enteropathy (coeliac disease) revealed by resistance to treatment with levothyroxine and alfacalcidol in a sixty-eight-year-old patient: a case report. Thyroid 12:633\u2013636","journal-title":"Thyroid"},{"key":"706_CR107","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1507\/endocrj.47.45","volume":"47","author":"D Ogawa","year":"2000","unstructured":"Ogawa D, Otsuka F, Mimura U et al (2000) Pseudomalabsorption of levothyroxine: a case report. Endocr J 47:45\u201350","journal-title":"Endocr J"},{"key":"706_CR108","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4158\/endp.20.5.028633k1031088p1","volume":"20","author":"S Benvenga","year":"2014","unstructured":"Benvenga S (2014) Solution of a diagnostic problem upon visiting the patient at home and reading their medication leaflet. Endocr Pract 20:517","journal-title":"Endocr Pract"},{"key":"706_CR109","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/thy.2007.0060","volume":"17","author":"J John-Kalarickal","year":"2007","unstructured":"John-Kalarickal J, Pearlman G, Carlson HE (2007) New medications which decrease levothyroxine absorption. Thyroid 17:763\u2013765","journal-title":"Thyroid"},{"key":"706_CR110","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1089\/105072501753211046","volume":"11","author":"N Singh","year":"2001","unstructured":"Singh N, Weisler SL, Hershman JM (2001) The acute effect of calcium carbonate on the intestinal absorption of levothyroxine. Thyroid 11:967\u2013971","journal-title":"Thyroid"},{"key":"706_CR111","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.3748\/wjg.v20.i30.10331","volume":"20","author":"E Lahner","year":"2014","unstructured":"Lahner E, Virili C, Santaguida MG, Annibale B, Centanni M (2014) Helicobacter pylori infection and drugs malabsorption. World J Gastroenterol 20:10331\u201310337","journal-title":"World J Gastroenterol"},{"key":"706_CR112","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjmed.2007.09.025","volume":"121","author":"E Lahner","year":"2008","unstructured":"Lahner E, Centanni M, Agnello G et al (2008) Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis. Am J Med 121:136\u2013141","journal-title":"Am J Med"},{"key":"706_CR113","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3748\/wjg.14.563","volume":"14","author":"E Lahner","year":"2008","unstructured":"Lahner E, Intraligi M, Buscema M et al (2008) Artificial neural networks in the recognition of the presence of thyroid disease in patients with atrophic body gastritis. W J Gastroenterol 14:563\u2013568","journal-title":"W J Gastroenterol"},{"key":"706_CR114","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.clpt.2005.06.010","volume":"78","author":"JW Groot de","year":"2005","unstructured":"de Groot JW, Zonnenberg BA, Plukker JT, van Der Graaf WT, Links TP (2005) Imatinib induces hypothyroidism in patients receiving levothyroxine. Clin Pharmacol Ther 78:433\u2013438","journal-title":"Clin Pharmacol Ther"},{"key":"706_CR115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa075853","volume":"359","author":"SI Sherman","year":"2008","unstructured":"Sherman SI, Wirth LJ, Droz JP et al (2008) Motesanib diphosphate in progressive differentiated thyroid cancer. N Engl J Med 359:31\u201342","journal-title":"N Engl J Med"},{"key":"706_CR116","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1179\/joc.2007.19.3.352","volume":"19","author":"SI Robinson","year":"2007","unstructured":"Robinson SI, Hobday TJ, Sathananthan A, Morris JC 3rd, McWilliams RR (2007) Can sorafenib cause hypothyroidism? J Chemother 19:352\u2013353","journal-title":"J Chemother"},{"key":"706_CR117","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4158\/EP10224.CR","volume":"16","author":"V Srinivas","year":"2010","unstructured":"Srinivas V, Oyibo SO (2010) Levothyroxine pseudomalabsorption and thyroxine absorption testing with use of high-dose levothyroxine: case report and discussion. Endocr Pract 16:1012\u20131015","journal-title":"Endocr Pract"},{"key":"706_CR118","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1055\/s-0028-1082836","volume":"134","author":"K M\u00fcssig","year":"2009","unstructured":"M\u00fcssig K, M\u00f6rike K, Klein R (2009) Hypothyroidism due to pseudo-malabsorption of levothyroxine\u2014case 12\/2009. Dtsch Med Wochenschr 134:2514","journal-title":"Dtsch Med Wochenschr"},{"key":"706_CR119","first-page":"870","volume":"82","author":"SK Grebe","year":"1997","unstructured":"Grebe SK, Cooke RR, Ford HC et al (1997) Treatment of hypothyroidism with once weekly thyroxine. J Clin Endocrinol Metab 82:870\u2013875","journal-title":"J Clin Endocrinol Metab"},{"key":"706_CR120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12020-016-1035-1","volume":"54","author":"C Virili","year":"2016","unstructured":"Virili C, Trimboli P, Romanelli F, Centanni M (2016) Liquid and softgel levothyroxine use in clinical practice: state of the art. Endocrine 54:3\u201314","journal-title":"Endocrine"},{"key":"706_CR121","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12020-014-0476-7","volume":"49","author":"MG Santaguida","year":"2015","unstructured":"Santaguida MG, Virili C, Del Duca SC, Cellini M, Gatto I, Brusca N et al (2015) Thyroxine softgel capsule in patients with gastric-related T4 malabsorption. Endocrine 49:51\u201357","journal-title":"Endocrine"},{"key":"706_CR122","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40268-016-0150-z","volume":"17","author":"FR Ernst","year":"2017","unstructured":"Ernst FR, Sandulli W, Elmor R et al (2017) Retrospective study of patients switched from tablet formulations to a gel cap formulation of levothyroxine: results of the CONTROL Switch study. Drugs R D 17:103\u2013115","journal-title":"Drugs R D"},{"key":"706_CR123","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s12020-015-0836-y","volume":"52","author":"P Fallahi","year":"2016","unstructured":"Fallahi P, Ferrari SM, Antonelli A (2016) Oral l-thyroxine liquid versus tablets in patients with hypothyroidism without malabsorption: a prospective study. Endocrine 52:597\u2013601","journal-title":"Endocrine"},{"key":"706_CR124","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s40618-014-0181-7","volume":"38","author":"F Trimarchi","year":"2015","unstructured":"Trimarchi F (2015) Clinical endocrinology in the near future: a post-modern challenge. J Endocrinol Invest 38:95\u201399","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-017-0706-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0706-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0706-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T18:22:05Z","timestamp":1602440525000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-017-0706-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,10]]},"references-count":124,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["706"],"URL":"https:\/\/doi.org\/10.1007\/s40618-017-0706-y","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,10]]}}}